Dr. Easa Ghoreishi, MD

Dr. Ghoreishi practices at Hazel Hawkins Memorial Hospital in Hollister, California, part of Hazel Hawkins.

Dr. Ghoreishi's NPI, 1417942228, was assigned on September 19, 2005. Dr. Ghoreishi graduated from Isfahan University of Medical Sciences in 1991. Dr. Ghoreishi holds California license C147933.

Dr. Ghoreishi's primary practice is Hazel Hawkins Memorial Hospital, at 911 Sunset Drive, Hollister, CA 95032 in Santa Clara County. The practice phone is (831) 637-5711.

Dr. Ghoreishi's primary practice is Hazel Hawkins Memorial Hospital in Hollister, California, part of Hazel Hawkins. Dr. Ghoreishi is also affiliated with Adventist Health Bakersfield. The medical group on file is Big River Emergency Physicians Inc. Dmand AI also links Dr. Ghoreishi to 2 more hospitals and 11 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghoreishi practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Ghoreishi's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Ghoreishi is board certified in emergency medicine by the American Board of Physician Specialties (ABPS). Dmand AI has Dr. Ghoreishi's licenses on file in 5 states: California, Arizona, Indiana, Michigan and Ohio.

CMS data shows 737 Medicare services from Dr. Ghoreishi across 5 procedure codes in 2024, for 451 Medicare patients. Medicare paid $63,381 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 451 Medicare patients who saw Dr. Ghoreishi in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghoreishi's median patient age at 40, with 57% women.

In 2024, Dr. Ghoreishi wrote 679 Medicare Part D claims for 342 patients. 94% of them were for generic drugs. CMS names the drug for 458 of them, across 16 drugs with 11 or more claims each, at $2,600 in total drug cost. In 2023, CMS named 387 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ghoreishi for performance year 2024, reported as part of a group. Dr. Ghoreishi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 73 general payments to Dr. Ghoreishi from 4 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 52% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $13,092.

Dmand AI lists 8 awards for Dr. Ghoreishi, most recently Top 10%, America's Most Honored Professionals in 2017.

Dr. Ghoreishi graduated from Isfahan University of Medical Sciences in 1991. Dr. Ghoreishi is a member of AAFP.

Dr. Ghoreishi is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.